HANNAH HARRISON: Open Payments
NPI 1871219428 · ALIQUIPPA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 42 payments from 14 companies in 2025. Trend: 2023 $504 · 2024 $215 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $400 |
| Vanda Pharmaceuticals Inc. | 6 | $139 |
| Otsuka America Pharmaceutical, Inc. | 3 | $87 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| ABBVIE INC. | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 1 | $38 |
| Lundbeck LLC | 2 | $33 |
| Corium, LLC | 3 | $33 |
Products named: CAPLYTA, REXULTI, FANAPT, Auvelity, HETLIOZ, Jornay PM, VRAYLAR, SPRAVATO.
Industry payments across PA — which companies pay providers there.
